Artesunate

青蒿琥酯

Report date: 2025/03/06 16:50:10
NME

Base Information

Drug NameArtesunate
Drug Alias NameArtesunic acid青蒿琥脂青蒿酯ArgesunArtesunatum +[15] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSarcoplasmic/endoplasmic reticulum calcium ATPase 2 inhibitorsSarcoplasmic/endoplasmic reticulum calcium ATPase 1 inhibitors
TargetsSarcoplasmic/endoplasmic reticulum calcium ATPase 2Sarcoplasmic/endoplasmic reticulum calcium ATPase 1
Therapy Area/IndicationsMetastatic breast cancerSolid tumoursAnal intraepithelial neoplasia +[27] 
Global Approved IndicationsMalaria
Approved Indications in ChinaMalaria
Original Approved Country/TerritoryMainland China
Original Approved Date1988/01/01
Country/TerritoryBelgiumUnited StatesVietnam +[17] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesShanghai Fosun Pharmaceutical (Group) Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesInstitut National De La Santé Et De La Recherche Médicale, France U979Frantz Viral Therapeutics LlcMetanoic Health Ltd +[12] 
Inactive CompaniesInstitute Of Tropical Medicine, University Of TuebingenKinshasa School Of Public HealthInstitut Für Klinische Und Molekulare Virologie +[12] 
Active IndicationsAnal intraepithelial neoplasiaVulvar DiseasesUterine Cervical Incompetence +[18] 
Inactive IndicationsMetastatic breast cancerSolid tumoursBreast Neoplasms +[9] 

Other Information

ATC CodeP01BE03
Related LinksWikipediaDrugBankKEGG